(Q46432103)

English

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

scientific article published on 22 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

hyperparathyroidism

1 reference

based on heuristic

inferred from title

Robert Elashoff

6

object named as

Robert Elashoff

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

Harald Jüppner

7

object named as

Harald Jüppner

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

8

object named as

Isidro B Salusky

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

4

object named as

Barbara Gales

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

Katherine Wesseling-Perry

1

object named as

Katherine Wesseling-Perry

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

author name string

Renata C Pereira

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

Shobha Sahney

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

He-Jing Wang

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

language of work or name

0 references

publication date

22 September 2010

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

Kidney International

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

79

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

112-119

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

https://scigraph.springernature.com/pub.10.1038/ki.2010.352

0 references

Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Early Subclinical Coronary Artery Calcification in Young Adults Who Were Pediatric Kidney Transplant Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

"High-dose" calcitriol for control of renal osteodystrophy in children on CAPD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Arterial calcifications and bone histomorphometry in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of serum aluminum values with tissue aluminum concentration.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and distribution of aluminium in bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative review of the pharmacokinetics of vitamin D analogues

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality risk among hemodialysis patients receiving different vitamin D analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Sevelamer hydrochloride: an effective phosphate binder in dialyzed children

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone disease in children and adolescents undergoing successful renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.352

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/KI.2010.352

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/20861820

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46432103&oldid=2111180188"